These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30705707)

  • 41. Identification and characterization of novel synthetic cannabinoid ethyl-2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-EDMB-PICA).
    Xu F; Wei W; Shan X; Wang R; Liu L
    Forensic Toxicol; 2022 Jan; 40(1):163-172. PubMed ID: 36454500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
    Noble C; Cannaert A; Linnet K; Stove CP
    Drug Test Anal; 2019 Mar; 11(3):501-511. PubMed ID: 30280499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A synthetic cannabinoid FDU-NNEI, two 2
    Uchiyama N; Shimokawa Y; Kikura-Hanajiri R; Demizu Y; Goda Y; Hakamatsuka T
    Forensic Toxicol; 2015; 33(2):244-259. PubMed ID: 26257833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases.
    Wagmann L; Stiller RG; Fischmann S; Westphal F; Meyer MR
    Arch Toxicol; 2022 Oct; 96(10):2755-2766. PubMed ID: 35788413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
    Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in early 2017.
    Ernst L; Brandhorst K; Papke U; Altrogge A; Zodel S; Langer N; Beuerle T
    Forensic Sci Int; 2017 Aug; 277():51-58. PubMed ID: 28601726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analyte protectant approach to protect amide-based synthetic cannabinoids from degradation and esterification during GC-MS analysis.
    Mohamed Masoud KM; Syed SM; Alasiri AM
    J Chromatogr A; 2024 Aug; 1730():465022. PubMed ID: 38861824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18.
    Kevin RC; Lefever TW; Snyder RW; Patel PR; Gamage TF; Fennell TR; Wiley JL; McGregor IS; Thomas BF
    Drug Test Anal; 2018 Jan; 10(1):137-147. PubMed ID: 28834241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The 2-alkyl-2
    Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M
    Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings.
    Ti L; Tobias S; Maghsoudi N; Milloy MJ; McDonald K; Shapiro A; Beriault D; Stefan C; Lysyshyn M; Werb D
    Drug Alcohol Rev; 2021 May; 40(4):580-585. PubMed ID: 33354869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
    Krotulski AJ; Mohr ALA; Logan BK
    J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in summer 2018.
    Ernst L; Langer N; Bockelmann A; Salkhordeh E; Beuerle T
    Forensic Sci Int; 2019 Jan; 294():96-102. PubMed ID: 30497049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic cannabinoids in e-liquids: A proton and fluorine NMR analysis from a conventional spectrometer to a compact one.
    Wu N; Danoun S; Balayssac S; Malet-Martino M; Lamoureux C; Gilard V
    Forensic Sci Int; 2021 Jul; 324():110813. PubMed ID: 33993010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017.
    Somerville RF; Hassan VR; Kolbe E; Partington HK; Walsh KAJ; Kappatos DC; Johnson CS
    Forensic Sci Int; 2019 Jul; 300():19-27. PubMed ID: 31063884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11.
    Kevin RC; Cairns EA; Boyd R; Arnold JC; Bowen MT; McGregor IS; Banister SD
    Front Psychiatry; 2022; 13():1048836. PubMed ID: 36590635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F-MDMB-PICA.
    Chen RJ; Zhang ZH; Yang S; Yu SC; Wang JC; Liao PY; Qiu TT; Xiao L; Xue S; Chen H; Shao WB; Hu JW; Lan Y; Chen XL; Xu Y; Zhou TM; Zhao XJ; Liu WB
    Drug Test Anal; 2024 Mar; ():. PubMed ID: 38488339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The synthetic cannabinoid 5F-MDMB-PICA enhances the metabolic activity and angiogenesis in human brain microvascular endothelial cells by upregulation of VEGF, ANG-1, and ANG-2.
    Al-Eitan LN; Alahmad SZ; ElMotasem MFM; Alghamdi MA
    Toxicol Res (Camb); 2023 Oct; 12(5):796-806. PubMed ID: 37915478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of the Synthetic Cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in Plant Material and Quantification in Post-Mortem Blood Samples.
    Yeter O
    J Anal Toxicol; 2017 Nov; 41(9):720-728. PubMed ID: 28977413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19).
    Institóris L; Kovács K; Sija É; Berkecz R; Körmöczi T; Németh I; Elek I; Bakos Á; Urbán I; Pap C; Kereszty É
    Clin Toxicol (Phila); 2022 Jan; 60(1):18-24. PubMed ID: 34080493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.